Woodline Partners’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.9M | Buy |
567,894
+1,623
| +0.3% | +$82.6K | 0.15% | 203 |
|
|
2025
Q1 | $25.5M | Buy |
566,271
+161,867
| +40% | +$7.29M | 0.17% | 181 |
|
|
2024
Q4 | $16.7M | Buy |
404,404
+73,399
| +22% | +$3.04M | 0.11% | 244 |
|
|
2024
Q3 | $12.9M | Buy |
331,005
+127,285
| +62% | +$4.96M | 0.11% | 254 |
|
|
2024
Q2 | $6.97M | Sell |
203,720
-29,547
| -13% | -$1.01M | 0.07% | 295 |
|
|
2024
Q1 | $5.86M | Sell |
233,267
-19,996
| -8% | -$502K | 0.05% | 339 |
|
|
2023
Q4 | $7.48M | Sell |
253,263
-199,444
| -44% | -$5.89M | 0.08% | 260 |
|
|
2023
Q3 | $14.3M | Buy |
452,707
+124,889
| +38% | +$3.95M | 0.17% | 172 |
|
|
2023
Q2 | $8.48M | Sell |
327,818
-196,062
| -37% | -$5.07M | 0.1% | 225 |
|
|
2023
Q1 | $12.6M | Buy |
523,880
+163,288
| +45% | +$3.92M | 0.17% | 170 |
|
|
2022
Q4 | $7.03M | Buy |
360,592
+3,640
| +1% | +$71K | 0.09% | 266 |
|
|
2022
Q3 | $7.5M | Buy |
+356,952
| New | +$7.5M | 0.1% | 232 |
|